Application | Comment | Organism |
---|---|---|
medicine | DPP-IV is a target for the treatment of type 2 diabetes. The inhibitors vildagliptin and saxagliptin are well tolerated and reduce blood glucose and HbA1c levels in diabetic patients | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
saxagliptin | - |
Homo sapiens | |
vildagliptin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
DPP-IV | - |
Homo sapiens |